Ancora Heart
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4001 Burton Dr, Santa Clara, California,...Phone Number
(408) 727-1105Website
www.ancoraheart.comRevenue
$15.7 MillionIndustry
About Ancora Heart
Ancora Heart is a medical device company focused on developing innovative solutions for heart failure treatment. Their flagship product, the AccuCinch® Ventricular Restoration System, is designed to improve the quality of life for patients suffering from heart failure, particularly those with reduced ejection fraction. The company is actively conducting clinical trials to evaluate the effectiveness of their device and is committed to advancing treatment options for patients and physicians alike. Ancora Heart aims to provide hope and improved outcomes for millions affected by this debilitating condition.Explore more
Ancora Heart Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ancora Heart
Compare insights from companies similar to Ancora Heart, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ancora Heart
$15.7M
11-50
Private
$98.2M
2001
BB
Bart BeasleyAt Ancora Heart, Inc Vice President, Strategic Initiatives
Ancora Heart Tech Stack
A closer look at the technologies used by Ancora Heart
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ancora Heart
Sign Up For FreeTo access detailed company insights
Ancora Heart is a medical device company focused on developing innovative solutions for heart failure treatment. Their flagship product, the AccuCinch® Ventricular Restoration System, is designed to improve the quality of life for patients suffering from heart failure, particularly those with reduced ejection fraction. The company is actively condu... Read More
